Quantifying benefits and risks of vaccinating Australian children aged six months to four years with trivalent inactivated seasonal influenza vaccine in 2010

被引:0
|
作者
Kelly, H. [1 ]
Carcione, D. [2 ]
Dowse, G. [2 ]
Effler, P. [2 ]
机构
[1] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia
[2] Dept Hlth Western Australia, Communicable Dis Control Directorate, Perth, WA, Australia
来源
EUROSURVEILLANCE | 2010年 / 15卷 / 37期
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Australian and New Zealand health authorities identified seasonal trivalent inactivated influenza vaccines manufactured by CSL Biotherapies as the probable cause of increased febrile convulsions in children under five within 24 hours of vaccination and recommended against their use in this age group. We quantified the benefit-risk profile of the CSL vaccines using the number needed to vaccinate and suggest they might have caused two to three hospital admissions due to febrile convulsions for every hospital admission due to influenza prevented.
引用
收藏
页码:3 / 6
页数:4
相关论文
共 50 条
  • [1] Benefit and risks of trivalent 2010 seasonal influenza vaccine in Australian children
    Lopert, R.
    [J]. EUROSURVEILLANCE, 2010, 15 (40): : 21 - 21
  • [2] Authors' reply: Benefit and risks of trivalent 2010 seasonal influenza vaccine in Australian children
    Kelly, H.
    Carcione, D.
    Dowse, G.
    Effler, P.
    [J]. EUROSURVEILLANCE, 2010, 15 (40): : 22 - 23
  • [3] Safety of Trivalent Inactivated Influenza Vaccine in Children Aged 24 to 59 Months in the Vaccine Safety Datalink
    Glanz, Jason M.
    Newcomer, Sophia R.
    Hambidge, Simon J.
    Daley, Matthew F.
    Narwaney, Komal J.
    Xu, Stan
    Lee, Grace M.
    Baggs, James
    Klein, Nicola P.
    Nordin, James D.
    Naleway, Allison L.
    Belongia, Edward A.
    Weintraub, Eric S.
    [J]. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2011, 165 (08): : 749 - 755
  • [4] The effectiveness of trivalent inactivated influenza vaccine in children over six consecutive influenza seasons
    Katayose, Masahiko
    Hosoya, Mitsuaki
    Haneda, Takashi
    Yamaguchi, Hideo
    Kawasaki, Yukihiko
    Sato, Masatoki
    Wright, Peter F.
    [J]. VACCINE, 2011, 29 (09) : 1844 - 1849
  • [5] Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old
    Hambidge, Simon J.
    Glanz, Jason M.
    France, Eric K.
    McClure, David
    Xu, Stanley
    Yamasaki, Kristi
    Jackson, Lisa
    Mullooly, John P.
    Zangwill, Kenneth M.
    Marcy, S. Michael
    Black, Steven B.
    Lewis, Edwin M.
    Shinefield, Henry R.
    Belongia, Edward
    Nordin, James
    Chen, Robert T.
    Shay, David K.
    Davis, Robert L.
    DeStefano, Frank
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (16): : 1990 - 1997
  • [6] Immunogenicity and safety of a trivalent inactivated 2010-2011 influenza vaccine in Taiwan infants aged 6-12 months
    Hwang, Kao-Pin
    Hsu, Yu-Lung
    Hsieh, Tsung-Hsueh
    Lin, Hsiao-Chuan
    Yen, Ting-Yu
    Wei, Hsiu-Mei
    Lin, Hung-Chih
    Chen, An-Chyi
    Chow, Julie Chi
    Huang, Li-Min
    [J]. VACCINE, 2014, 32 (21) : 2469 - 2473
  • [7] Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study
    Heinonen, Santtu
    Silvennoinen, Heli
    Lehtinen, Pasi
    Vainionpaa, Raija
    Ziegler, Thedi
    Heikkinen, Terho
    [J]. LANCET INFECTIOUS DISEASES, 2011, 11 (01): : 23 - 29
  • [8] Evaluation of inactivated influenza vaccine in children aged 6-36 months
    Maeda, A
    Kohdera, U
    Fujieda, M
    Kase, T
    Hirota, Y
    [J]. OPTIONS FOR THE CONTROL OF INFLUENZA V, 2004, 1263 : 666 - 669
  • [9] A Randomized Trial of Candidate Inactivated Quadrivalent Influenza Vaccine versus Trivalent Influenza Vaccines in Children Aged 3-17 Years
    Domachowske, Joseph B.
    Pankow-Culot, Heidemarie
    Bautista, Milagros
    Feng, Yang
    Claeys, Carine
    Peeters, Mathieu
    Innis, Bruce L.
    Jain, Varsha
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2013, 207 (12): : 1878 - 1887
  • [10] Uptake and Effectiveness of a Trivalent Inactivated Influenza Vaccine in Children in Urban and Rural Kenya, 2010 to 2012
    Katz, Mark A.
    Lebo, Emmaculate
    Emukule, Gideon O.
    Otieno, Nancy
    Caselton, Deborah L.
    Bigogo, Godfrey
    Njuguna, Henry
    Muthoka, Philip M.
    Waiboci, Lilian W.
    Widdowson, Marc-Alain
    Xu, Xiyan
    Njenga, Moses K.
    Mott, Joshua A.
    Breiman, Robert F.
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (03) : 322 - 329